{"filing":{"accession_number":"0001628280-26-049822","cik":"0000771856","ticker":"CSBR","company_name":"CHAMPIONS ONCOLOGY, INC.","form":"8-K","filing_date":"2026-07-27","report_date":"2026-07-27","primary_document":"csbr-20260727.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/771856/000162828026049822/csbr-20260727.htm"},"events":[{"id":20738,"run_id":18663,"accession_number":"0001628280-26-049822","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Champions Oncology issued a press release on July 27, 2026 disclosing audited financial results for fiscal year ended April 30, 2026, including record annual revenue of $59.4 million, fourth consecutive quarter of positive adjusted EBITDA, and detailed quarterly and year-to-date financial performance. This is a standard earnings release disclosure under Item 2.02 with the press release attached as Exhibit 99.1.","company_name":"CHAMPIONS ONCOLOGY, INC.","ticker":"CSBR","filing_date":"2026-07-27","form":"8-K","submitted_at":null,"items":[{"id":20192,"accession_number":"0001628280-26-049822","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Champions Oncology issued a press release on July 27, 2026 disclosing audited financial results for fiscal year ended April 30, 2026, including record annual revenue of $59.4 million, fourth consecutive quarter of positive adjusted EBITDA, and detailed quarterly and year-to-date financial performance. This is a standard earnings release disclosure under Item 2.02 with the press release attached as Exhibit 99.1.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-27T20:33:53.900364+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":20192,"accession_number":"0001628280-26-049822","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Champions Oncology issued a press release on July 27, 2026 disclosing audited financial results for fiscal year ended April 30, 2026, including record annual revenue of $59.4 million, fourth consecutive quarter of positive adjusted EBITDA, and detailed quarterly and year-to-date financial performance. This is a standard earnings release disclosure under Item 2.02 with the press release attached as Exhibit 99.1.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-27T20:33:53.900364+00:00","company_name":"CHAMPIONS ONCOLOGY, INC.","ticker":"CSBR","filing_date":"2026-07-27"}]}